Scar Treatment Market By Scar Type, By Product, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

Description

List of Tables

Scar is a mark remaining on the skin after injured tissue has healed. Scars are known to produce deep structural changes inside the deep layers of skin. Scares are classified into atrophic scars, hypertrophic scars, contractures, stretch marks, and keloid scars. Scar treatment is carried out to improve or reduce appearance of scars. It also restores function and corrects skin changes (disfigurement) caused by an injury, wound, poor healing, or previous surgery. Scars can be treated with radiation, lasers treatment, polyurethane dressing, silicone gel, corticosteroid injections, cryosurgery, and bleomycin injections.

Rise in number of road accidents and burn incidences boosts growth of the market. Road accidents and burn cases are responsible for scar formation. For instance, according to the National Highway Traffic Safety Administration (NHTSA) of the U.S. Department of Transportation in 2020, 38,680 people died in motor vehicle traffic crashes. in addition, some accients requires surgical operation which further contributes in the growth of scar treatment market.

Furthermore, increase in demand for cosmetic surgeries to improve appearance and restore scar marks propel growth of the market. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS) survey, in 2020 around 10,129,528 cosmetic surgical procedures were carried worldwide.

Moreover, increase in R&D activities and novel product launches in the market by key players boost the market growth. For instance, in September, 2021, SkinCeuticals, a leading medical skincare brand, launched Advanced scar control gel, specifically formulated for different types of scars and ideal complement to post-procedure scar care for procedures such as Mohs surgery and scar revision surgery. Furthermore, rise in number of hospitals and improvements in healthcare infrastructure further contributes toward the market growth. However, high cost of scar treatment limits growth of the market.

The scar treatment market is segmented on the basis of scar type, product, end user, and region. By scar type, the market is divided into atrophic scars, hypertrophic & keloid scars, contractures, and stretch marks. By product, it is divided into topical, laser-based treatment, and others. By end user, it is divided into hospitals, clinics, and home care. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the scar treatment market analysis from 2021 to 2031 to identify the prevailing scar treatment market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the scar treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global scar treatment market size.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global scar treatment market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Scar Type

Atrophic Scar
Hypertrophic and Keloid Scar
Contractures
Stretch Marks

By Product

Topical
Laser based treatment
Others

By End User

Hospitals
Clinics
Home Care

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Avita Medical Limited
- Bausch Health Companies Inc.
- Cynosure, Inc.
- hra pharma
- Molnlycke Health Care AB
- Polytech Health & Aesthetics GmbH
- Sientra, Inc.
- sisram inc
- Smith and Nephew plc.

Product Code: A13439

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: SCAR TREATMENT MARKET, BY SCAR TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Atrophic Scar
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Hypertrophic and Keloid Scar
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
4.4 Contractures
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
4.5 Stretch Marks
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country

CHAPTER 5: SCAR TREATMENT MARKET, BY PRODUCT

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Topical
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Laser based treatment
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country

CHAPTER 6: SCAR TREATMENT MARKET, BY END USER

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Clinics
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Home Care
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: SCAR TREATMENT MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Scar Type
- 7.2.3 North America Market size and forecast, by Product
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Scar Type
  - 7.2.5.1.2 Market size and forecast, by Product
  - 7.2.5.1.3 Market size and forecast, by End User
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Scar Type
  - 7.2.5.2.2 Market size and forecast, by Product
  - 7.2.5.2.3 Market size and forecast, by End User
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Scar Type
  - 7.2.5.3.2 Market size and forecast, by Product
  - 7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Scar Type
- 7.3.3 Europe Market size and forecast, by Product
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Scar Type
  - 7.3.5.1.2 Market size and forecast, by Product
  - 7.3.5.1.3 Market size and forecast, by End User
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Scar Type
  - 7.3.5.2.2 Market size and forecast, by Product
  - 7.3.5.2.3 Market size and forecast, by End User
  - 7.3.5.3 U.K.
  - 7.3.5.3.1 Market size and forecast, by Scar Type
  - 7.3.5.3.2 Market size and forecast, by Product
  - 7.3.5.3.3 Market size and forecast, by End User
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Scar Type
  - 7.3.5.4.2 Market size and forecast, by Product
  - 7.3.5.4.3 Market size and forecast, by End User
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Scar Type
  - 7.3.5.5.2 Market size and forecast, by Product
  - 7.3.5.5.3 Market size and forecast, by End User
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Scar Type
  - 7.3.5.6.2 Market size and forecast, by Product
  - 7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Scar Type
- 7.4.3 Asia-Pacific Market size and forecast, by Product
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Scar Type
  - 7.4.5.1.2 Market size and forecast, by Product
  - 7.4.5.1.3 Market size and forecast, by End User
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Scar Type
  - 7.4.5.2.2 Market size and forecast, by Product
  - 7.4.5.2.3 Market size and forecast, by End User
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Market size and forecast, by Scar Type
  - 7.4.5.3.2 Market size and forecast, by Product
  - 7.4.5.3.3 Market size and forecast, by End User
  - 7.4.5.4 India
  - 7.4.5.4.1 Market size and forecast, by Scar Type
  - 7.4.5.4.2 Market size and forecast, by Product
  - 7.4.5.4.3 Market size and forecast, by End User
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Scar Type
  - 7.4.5.5.2 Market size and forecast, by Product
  - 7.4.5.5.3 Market size and forecast, by End User
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Market size and forecast, by Scar Type
  - 7.4.5.6.2 Market size and forecast, by Product
  - 7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Scar Type
- 7.5.3 LAMEA Market size and forecast, by Product
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Scar Type
  - 7.5.5.1.2 Market size and forecast, by Product
  - 7.5.5.1.3 Market size and forecast, by End User
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Scar Type
  - 7.5.5.2.2 Market size and forecast, by Product
  - 7.5.5.2.3 Market size and forecast, by End User
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Scar Type
  - 7.5.5.3.2 Market size and forecast, by Product
  - 7.5.5.3.3 Market size and forecast, by End User
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Scar Type
  - 7.5.5.4.2 Market size and forecast, by Product
  - 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Avita Medical Limited
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 Bausch Health Companies Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 Cynosure, Inc.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 hra pharma
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 Molnlycke Health Care AB
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Polytech Health & Aesthetics GmbH
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 Sientra, Inc.
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 sisram inc
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Smith and Nephew plc.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments